Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Collegium Pharmaceutical ...

    NASDAQ: COLL · Real-Time Price · USD
    30.19
    0.69 (2.34%)
    At close: Jun 06, 2025, 3:59 PM
    30.20
    0.03%
    After-hours: Jun 06, 2025, 04:58 PM EDT

    Collegium Pharmaceutical Statistics

    Share Statistics

    Collegium Pharmaceutical has 32.14M shares outstanding. The number of shares has increased by -3.76% in one year.

    Shares Outstanding

    n/a
    		 32.14M

    Shares Change (YoY)

    n/a
    		 -3.76%

    Shares Change (QoQ)

    n/a
    		 -2.37%

    Owned by Institutions (%)

    n/a
    		 99.99%

    Shares Floating

    n/a
    		 30.8M

    Failed to Deliver (FTD) Shares

    n/a
    		 8

    FTD / Avg. Volume

    n/a
    		 n/a

    Short Selling Information

    The latest short interest is 5.08M, so 15.79% of the outstanding shares have been sold short.

    Short Interest

    n/a
    		 5.08M

    Short % of Shares Out

    n/a
    		 15.79%

    Short % of Float

    n/a
    		 18.85%

    Short Ratio (days to cover)

    n/a
    		 14.47

    Valuation Ratios

    The PE ratio is 13.36 and the forward PE ratio is 4.2. Collegium Pharmaceutical's PEG ratio is 0.4.

    PE Ratio

    n/a
    		 13.36

    Forward PE

    n/a
    		 4.2

    PS Ratio

    n/a
    		 1.46

    Forward PS

    n/a
    		 1.3

    PB Ratio

    n/a
    		 4.04

    P/FCF Ratio

    n/a
    		 4.55

    PEG Ratio

    n/a
    		 0.4
    Financial Ratio History

    Enterprise Valuation

    Collegium Pharmaceutical has an Enterprise Value (EV) of 1.71B.

    EV / Sales

    n/a
    		 2.71

    EV / EBITDA

    n/a
    		 5.01

    EV / EBIT

    n/a
    		 8.36

    EV / FCF

    n/a
    		 8.43

    Financial Position

    The company has a current ratio of 0.95, with a Debt / Equity ratio of 3.75.

    Current Ratio

    n/a
    		 0.95

    Quick Ratio

    n/a
    		 0.88

    Debt / Equity

    n/a
    		 3.75

    Debt / EBITDA

    n/a
    		 2.51

    Debt / FCF

    n/a
    		 4.23

    Interest Coverage

    n/a
    		 2.3

    Financial Efficiency

    Return on Equity is 30.23% and Return on Invested Capital is 9.77%.

    Return on Equity

    n/a
    		 30.23%

    Return on Assets

    n/a
    		 4.16%

    Return on Invested Capital

    n/a
    		 9.77%

    Revenue Per Employee

    n/a
    		 $1,768,764.71

    Profits Per Employee

    n/a
    		 $193,809.52

    Employee Count

    n/a
    		 357

    Asset Turnover

    n/a
    		 0.38

    Inventory Turnover

    n/a
    		 7.15

    Taxes

    Income Tax

    n/a
    		 29.38M

    Effective Tax Rate

    n/a
    		 29.8%

    Stock Price Statistics

    The stock price has increased by -9.04% in the last 52 weeks. The beta is 0.65, so Collegium Pharmaceutical's price volatility has been higher than the market average.

    Beta

    n/a
    		 0.65

    52-Week Price Change

    n/a
    		 -9.04%

    50-Day Moving Average

    n/a
    		 28.21

    200-Day Moving Average

    n/a
    		 31.8

    Relative Strength Index (RSI)

    n/a
    		 62.1

    Average Volume (20 Days)

    n/a
    		 371,485

    Income Statement

    In the last 12 months, Collegium Pharmaceutical had revenue of 631.45M and earned 69.19M in profits. Earnings per share was 2.14.

    Revenue

    n/a
    		 631.45M

    Gross Profit

    n/a
    		 377.34M

    Operating Income

    n/a
    		 169.9M

    Net Income

    n/a
    		 69.19M

    EBITDA

    n/a
    		 341.7M

    EBIT

    n/a
    		 172.54M

    Earnings Per Share (EPS)

    n/a
    		 2.14
    Full Income Statement

    Balance Sheet

    The company has 70.56M in cash and 859.3M in debt, giving a net cash position of -788.73M.

    Cash & Cash Equivalents

    n/a
    		 70.56M

    Total Debt

    n/a
    		 859.3M

    Net Cash

    n/a
    		 -788.73M

    Retained Earnings

    n/a
    		 -164M

    Total Assets

    n/a
    		 1.63B

    Working Capital

    n/a
    		 40.84M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was 204.98M and capital expenditures -1.65M, giving a free cash flow of 203.33M.

    Operating Cash Flow

    n/a
    		 204.98M

    Capital Expenditures

    n/a
    		 -1.65M

    Free Cash Flow

    n/a
    		 203.33M

    FCF Per Share

    n/a
    		 6.3
    Full Cash Flow Statement

    Margins

    Gross margin is 59.76%, with operating and profit margins of 26.91% and 10.96%.

    Gross Margin

    n/a
    		 59.76%

    Operating Margin

    n/a
    		 26.91%

    Pretax Margin

    n/a
    		 15.61%

    Profit Margin

    n/a
    		 10.96%

    EBITDA Margin

    n/a
    		 54.11%

    EBIT Margin

    n/a
    		 26.91%

    FCF Margin

    n/a
    		 32.2%

    Dividends & Yields

    COLL does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 7.48%

    FCF Yield

    n/a
    		 21.99%
    Dividend Details

    Analyst Forecast

    The average price target for COLL is $44, which is 45.7% higher than the current price. The consensus rating is "Buy".

    Price Target

    n/a
    		 $44

    Price Target Difference

    n/a
    		 45.7%

    Analyst Consensus

    n/a
    		 Buy

    Analyst Count

    n/a
    		 5
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 $47.87

    Lynch Upside

    n/a
    		 58.56%

    Graham Number

    n/a
    		 18.49

    Graham Upside

    n/a
    		 -38.75%

    Scores

    Altman Z-Score

    n/a
    		 0.99

    Piotroski F-Score

    n/a
    		 5

    Add to Watchlist